Canine pyoderma gangrenosum: a case series of two dogs

Vet Dermatol. 2013 Oct;24(5):552-e132. doi: 10.1111/vde.12065. Epub 2013 Aug 9.

Abstract

Background: Pyoderma gangrenosum (PG) is a rare disease, which, to the best of the authors' knowledge, has been the subject of only one case report in the peer-reviewed veterinary literature.

Hypothesis/objectives: To describe the history, clinical signs, diagnostic findings and treatment outcome in two cases of canine PG.

Animals: Two client-owned dogs presented to a private veterinary referral practice between 2008 and 2010 who received a diagnosis of PG by specialist veterinary dermatologists.

Methods: Medical records were analysed to retrieve relevant information.

Results: Both dogs were treated with prednisolone; this was combined with ciclosporin in case 1 and azathioprine in case 2. Case 2 had a more complete response of lesions to treatment and a longer survival time after diagnosis (763 days) than case 1 (81 days).

Conclusions and clinical importance: Pyoderma gangrenosum is a rare disease distinguished by rapid progression of painful, necrolytic, cutaneous ulcers with irregular, violaceous undermined borders. Azathioprine with glucocorticoids may lead to a better outcome than ciclosporin and glucocorticoids (currently the first-line treatment in humans and the only reported treatment in dogs).

Publication types

  • Case Reports

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / therapeutic use
  • Dog Diseases / diagnosis
  • Dog Diseases / pathology*
  • Dogs
  • Male
  • Prednisolone / administration & dosage
  • Prednisolone / therapeutic use
  • Pyoderma Gangrenosum / diagnosis
  • Pyoderma Gangrenosum / pathology
  • Pyoderma Gangrenosum / veterinary*
  • Sulfasalazine / administration & dosage
  • Sulfasalazine / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Anti-Inflammatory Agents
  • Sulfasalazine
  • Prednisolone